Position in SNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$8,342,888
-$835,305 QoQ
Shares Held
195,567
+2.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#97
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. SNY ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
This page
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
|
21,433 | $7,761,317 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,342,888 | 195,567 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,178,193 | 190,498 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,539,033 | 73,030 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,722,564 | 36,495 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $289,860 | 6,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $332,760 | 6,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $385,840 | 8,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $461,040 | 8,000 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $388,160 | 8,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $388,800 | 8,000 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $397,840 | 8,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $709,657 | 13,230 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,124,354 | 20,860 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,135,201 | 20,860 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,010,249 | 20,860 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $793,097 | 20,860 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,043,625 | 20,860 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,070,952 | 20,860 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,327,650 | 26,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,784,243 | 78,495 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,594,730 | 144,222 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,480,877 | 373,653 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $17,618,393 | 362,593 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,869,149 | 356,172 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $17,091,693 | 334,803 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,473,510 | 79,449 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||